Research ArticleShort Communication
Minor Compensatory Changes in SAGE Mdr1a (P-gp), Bcrp, and Mrp2 Knockout Rats do not Detract from their General Utility in the Study of Transporter-mediated Pharmacokinetics
Maciej J Zamek-Gliszczynski, Keith M Goldstein, April Paulman, Thomas K Baker and Timothy P Ryan
Drug Metabolism and Disposition April 8, 2013, dmd.113.051409; DOI: https://doi.org/10.1124/dmd.113.051409
Maciej J Zamek-Gliszczynski
1 Eli Lilly and Company;
Keith M Goldstein
1 Eli Lilly and Company;
April Paulman
2 Covance Laboratories
Thomas K Baker
1 Eli Lilly and Company;
Timothy P Ryan
1 Eli Lilly and Company;
Jump to comment:
No eLetters have been published for this article.
In this issue
Research ArticleShort Communication
Minor Compensatory Changes in SAGE Mdr1a (P-gp), Bcrp, and Mrp2 Knockout Rats do not Detract from their General Utility in the Study of Transporter-mediated Pharmacokinetics
Maciej J Zamek-Gliszczynski, Keith M Goldstein, April Paulman, Thomas K Baker and Timothy P Ryan
Drug Metabolism and Disposition April 8, 2013, dmd.113.051409; DOI: https://doi.org/10.1124/dmd.113.051409
Research ArticleShort Communication
Minor Compensatory Changes in SAGE Mdr1a (P-gp), Bcrp, and Mrp2 Knockout Rats do not Detract from their General Utility in the Study of Transporter-mediated Pharmacokinetics
Maciej J Zamek-Gliszczynski, Keith M Goldstein, April Paulman, Thomas K Baker and Timothy P Ryan
Drug Metabolism and Disposition April 8, 2013, dmd.113.051409; DOI: https://doi.org/10.1124/dmd.113.051409
Jump to section
Related Articles
Cited By...
More in this TOC Section
Similar Articles
Advertisement